Survival of patients with visceral metastatic melanoma from an occult primary lesion: A retrospective matched cohort study

Annals of Oncology

Volumn 9, Issue 4, 1998, Pages 419-422

  Vijuk, G ^a   Coates, A S ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Melanoma; Occult; Prognosis; Survival

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BONE METASTASIS; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; MELANOMA; METASTASIS; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; SUBCUTANEOUS TISSUE;

EID: 0031744983     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008201931959     Document Type: Article

References (24)

1. Reintgen DS, McCarthy KS. Woodard B et al. Metastatic malignant melanoma with an unknown primary. Surg Gynecol Obstet 1983; 156: 335-40.
2. Das Gupta T, Bowden L, Berg NW. Malignant melanoma of unknown primary origin. Surg Gynecol Obstet 1963; 117: 341-5.
3. Baab GH, McBride CM. Malignant melanoma. The patient with an unknown site of primary origin. Arch Surg 1975; 110: 896-900.
4. Milton GW, Shaw HM, McCarthy WH. Occult primary malignant melanoma: Factors influencing survival. Br J Surg 1977; 64: 805-8.
5. Chang P, Knapper WH. Metastatic melanoma of unknown primary. Cancer 1982; 49: 1106-11.
6. Panagopoulos E, Murray D. Metastatic malignant melanoma of unknown primary origin: A study of 30 cases. J Surg Oncol 1983; 23: 8-10.
7. Nasri S, Mamazie A, Dulguerov P et al. Malignant melanoma of cervical and parotid lymph nodes with an unknown primary site. Laryngoscope 1994; 104: 1194-8.
8. Coates MS, Armstrong BK. Cancer in New South Wales: Incidence and mortality 1994. Kings Cross: NSW Cancer Council 1997; 48-9.
9. McCarthy WH, Shaw HM, Milton GW. Spontaneous regression of metastatic malignant melanoma. Clin Oncol 1978; 4: 203-7.
10. Shaw HM, McCarthy SW, McCarthy WH et al. Thin regressing malignant melanoma: Significance of concurrent regional lymph node metastases. Histopathology 1989; 15: 257-65.
11. Wong JH, Cagle LA, Morton DL. Surgical treatment of lymph nodes with metastatic melanoma from unknown primary site. Arch Surg 1987; 122: 1380-3.
12. Coates AS, Thomson D, McLeod GR et al. Prognostic value of quality of life scores in a trial of chemotherapy with or without interferon in patients with metastatic melanoma. Eur J Cancer 1993; 29A: 1731-4.
13. Peto R, Pike MC, Armitage P et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 1977; 35: 1-39.
14. Cox DR. Regression models and life tables (with discussion). J Roy Stat Soc 1972; B34: 187-220.
15. Gebski V, Leung O, McNeil DR, Lunn D. SPIDA Users Manual 2nd ed. Sydney: Statistical Computing Laboratory 1992.
16. Balch CM, Soong SJ, Shaw HM et al. An analysis of prognostic factors in 8500 patients with cutaneous melanoma. In Balch CM, Houghton AN, Milton GW et al. (eds): Cutaneous Melanoma. Philadelphia: JB Lippincott 1995; 165-87.
17. Sirott MN, Bajorin DF, Wong GY et al. Prognostic factors in patients with metastatic malignant melanoma. A multivariate analysis. Cancer 1993; 72: 3091-8.
18. Ryan L, Kramar A, Borden E. Prognostic factors in metastatic melanoma. Cancer 1993; 71: 2995-3005.
19. Maurer LH. McIntyre OR. Rueckert F. Spontaneous regression of malignant melanoma: Pathologic and immunologic study in a ten year survivor. Am J Surg 1974; 127: 397-402.
20. Sumner WC, Foraker AG. Spontaneous regression of human melanoma: Clinical and experimental study. Cancer 1960; 13: 79-81.
21. Giuliano AE, Cochran AJ, Morton DL. Melanoma from unknown primary site and amelanotic melanoma. Semin Oncol 1982; 4: 442-7.
22. Everson TC, Cole WH. Spontaneous Regression of Cancer. Philadelphia: WB Saunders 1966; 1-10, 164-220.
23. Kopf A, Bart RS, Rodriguez-Sains R. Malignant melanoma. A review: Occult primary malignant melanoma and spontaneous regression of malignant melanoma. J Dermatol Surg Oncol 1977; 3: 81-3.
24. Lopez R, Holyoke ED, Moore RH et al. Malignant melanoma with unknown primary site. J Surg Oncol 1982; 19: 151-4.